It is possible that APOE polymorphism collaborates with other comorbidity factors, such as obesity, chronic infection, hyperlipidemia, hypertension, and neurodegenerative disorders to exacerbate diabetes progression [14,122,123,124]. This evidence concerns the gene APOE and diabetes mellitus.